Kalaris Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.07

-0.15 (-3.44%)

As of Jun 30, 10:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +462.4% upside

Low Target $19.41

Average Target $22.89

High Target $38.59

Current Price $4.07

Current
$4.07

Target
$22.89

$19.41 $22.89 avg $38.59

Scenario Analysis

Bear Case

$19.41

376.9%

Low target

Base Case

$22.89

+462.4%

Avg target

Bull Case

$38.59

+848.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$11.88

-65.7% from high

52-Week Low

$2.14

+90.2% from low

Target vs 52W High

$22.89

+92.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%